Zhejiang Jingxin Pharmaceutical (002020.SZ) Earnings Analysis

Zhejiang Jingxin Pharmaceutical (002020.SZ) next reports earnings on 2026-08-21. It has beaten estimates in 3/3 recent quarters (100%). Trailing P/E 15.22.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002020.SZ next report earnings?

Next earnings date2026-08-21
Consensus EPS estimaten/a
Revenue estimaten/a

002020.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.22 CNYn/an/an/a
2025-04-270.1597 CNYn/an/an/a
2025-04-020.2 CNY0.18 CNY+11.1%Beat
2024-10-240.2008 CNY0.19 CNY+5.7%Beat
2024-08-140.2682 CNY0.21 CNY+27.7%Beat

Beat rate: 3/3 (100%) over reported quarters with consensus data.

002020.SZ valuation and analyst view

Trailing P/E15.22
Trailing EPS0.91995 CNY
Price / book1.92
Dividend yield2.47%
Market cap12.17B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Zhejiang Jingxin Pharmaceutical (002020.SZ)'s next earnings date?

Zhejiang Jingxin Pharmaceutical is next scheduled to report on 2026-08-21.

Did 002020.SZ beat earnings last quarter?

Consensus estimate data was not available for 002020.SZ's 2026-04-24 report.

What is 002020.SZ's earnings track record?

Over the last 3 reported quarters with consensus data, 002020.SZ beat estimates 3 times (100%).

What is 002020.SZ's current P/E ratio and EPS?

002020.SZ trades at a trailing P/E of 15.22 on trailing EPS of 0.9199455932278837 CNY.

What do analysts rate 002020.SZ?

002020.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.